Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3625
Selected: 0
NCT IDTitle
NCT06161571A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
NCT06439563Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers
NCT04900428Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK)
NCT00406887Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
NCT04681248Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors
NCT07502664Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)
NCT03379493Study of ET190L1 ARTEMIS™ T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's Lymphoma
NCT03277248Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS)
NCT02657330Study of SBP-101 in Pancreatic Cancer
NCT06153693Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension
NCT00363714A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
NCT05639933Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
NCT03828149Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults
NCT03292484Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
NCT02117830A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects
NCT07227103A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial
NCT07027111Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDP
NCT02296164Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma
NCT05336409A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies
NCT03251092Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis
NCT04358406Rhu-pGSN for Severe Covid-19 Pneumonia
NCT05103878A Phase 1, Single-Ascending-Dose Study of BT051 in Healthy Subjects
NCT06736418Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy
NCT05725018A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients
NCT02500199Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors
NCT05735015PTH-independent Effects of Encaleret
NCT06479135Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
NCT04845217Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
NCT02508389A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer
NCT00595920Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis
NCT02973620Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure
NCT07225959A Study of Annual Doses of MK-1406/CD388 in Healthy Adults (MK-1406-006/CD388.SQ.2.07)
NCT07176689Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
NCT01571297Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
NCT00225797Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain
NCT05438160Exploratory Study of a Digital Therapeutics in People With Schizophrenia
NCT02954991Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer
NCT01069120Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids
NCT07586618First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
NCT03099824A Phase 1 Study of the Safety and Pharmacokinetics of GC4711 (Oral Capsule) Compared to GC4419 (IV Infusion) and GC4711 (IV Infusion) in Healthy Volunteers
NCT03194555The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination
NCT06209580AMT-253 in Patients With Advanced Solid Tumours
NCT05285540Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia
NCT06133491Open Label, 6-month Study for High Frequency and Chronic Migraine,
NCT02643082A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD
NCT02505997Study to Evaluate the Effect of Delafloxacin on the Pharmacokinetics of Midazolam in Healthy Subjects
NCT03226574Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain
NCT02719574Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation
NCT00456521A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program
NCT01715168A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer